Organisation paid for research Program year 2024 Source: CMS Open Payments

Wirb

Neither a doctor nor a teaching hospital

Research payments

$279,259

234 payments

Through program year 2024, Wirb is reported as receiving $279,259 in research payments, across 234 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$19,567	1
2022	Research	$1,315	1
2021	Research	$39,768	14
2020	Research	$100,033	90
2019	Research	$118,576	128

Breakdown

Who paid Research payments · program years 2019–2024

CVRx, Inc. $133,763 165 payments
InSightec,Inc $87,838 37 payments
E.R. Squibb & Sons, L.L.C. $41,422 17 payments
Corcept Therapeutics $11,048 10 payments
Clovis Oncology, Inc. $3,535 4 payments
Ferring International Pharmascience Center US $1,653 1 payment

Studies the money was for Research payments · program years 2019–2024

Study name not reported $121,614 152 payments
Pd006 $41,579 12 payments
Phase I/II FIH Monotherapy/Combination $19,567 1 payment
Cort125281-601 $11,048 10 payments
Al002 $7,630 4 payments
PCa003 $7,545 7 payments
PD006, PCa003, ND001 $6,553 1 payment
Bm018, Pd006, Al002, Et002ca $6,068 1 payment
Pd002, Al002, Pd006 $5,950 1 payment
Study name not reported $5,161 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.